1,5-Anhydroglucitol (1,5-AG), Intermediate Glycemic Control

Sample type: Serum

Other names: 1, 5 AG, INTERMEDIATE GLYCEMIC CONTROL

Optimal result: 7.5 – 28.4 mcg/mL

1,5-Anhydroglucitol (1,5-AG) is a monosaccharide that plays a critical role as a biomarker in the assessment of intermediate glycemic control in individuals, particularly those with diabetes. Unlike conventional markers such as glycated hemoglobin (HbA1c), which reflects average blood glucose levels over a period of approximately two to three months, 1,5-AG offers a more immediate view of glycemic control, usually reflecting fluctuations in blood glucose levels over a shorter period of one to two weeks.

This distinct temporal sensitivity arises from its unique physiological mechanism: 1,5-AG is typically maintained at a constant level in the bloodstream, but when blood glucose levels rise above the renal threshold (approximately 180 mg/dL), glucose competes with 1,5-AG for reabsorption in the kidneys. As a result, elevated blood glucose levels lead to an increased excretion of 1,5-AG in urine, thereby reducing its serum concentration.

1,5-Anhydroglucitol (1,5-AG) is a monosaccharide that plays a critical role as a biomarker in the assessment of intermediate glycemic control in individuals, particularly those with diabetes. Unlike conventional markers such as glycated hemoglobin (HbA1c), which reflects average blood glucose levels over a period of approximately two to three months, 1,5-AG offers a more immediate view of glycemic control, usually reflecting fluctuations in blood glucose levels over a shorter period of one to two weeks.

This distinct temporal sensitivity arises from its unique physiological mechanism: 1,5-AG is typically maintained at a constant level in the bloodstream, but when blood glucose levels rise above the renal threshold (approximately 180 mg/dL), glucose competes with 1,5-AG for reabsorption in the kidneys. As a result, elevated blood glucose levels lead to an increased excretion of 1,5-AG in urine, thereby reducing its serum concentration.

This biomarker's sensitivity to short-term glycemic excursions makes it particularly useful in detecting and monitoring postprandial hyperglycemia and glycemic variability, both of which are significant factors in the pathogenesis of diabetic complications and may not be adequately captured by HbA1c alone. Consequently, 1,5-AG serves as a valuable adjunct to HbA1c in providing a comprehensive picture of glycemic control. It is particularly beneficial in situations where HbA1c readings may be misleading, such as in cases of hemoglobinopathies, recent changes in diabetes therapy, or pregnancy. Moreover, the assessment of 1,5-AG levels can be instrumental in guiding therapeutic adjustments in diabetes management, aiming for a holistic approach to the control of both fasting and postprandial blood glucose levels. However, it's important to note that the interpretation of 1,5-AG levels must be done cautiously, considering factors like renal function, as renal impairment can affect its accuracy as a glycemic marker.

Reference Range(s):

Age Male
(mcg/mL)
Female
(mcg/mL)
≤1 year Not established Not established
2-17 years 15.0-38.0 11.2-35.7
≥18 years 7.3-36.6 7.5-28.4
1,5-Anhydroglucitol (1,5-AG), Intermediate Glycemic Control
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond 1,5-Anhydroglucitol (1,5-AG), Intermediate Glycemic Control — 10,000+ markers explained
One 1,5-Anhydroglucitol (1,5-AG), Intermediate Glycemic Control result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro